Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiviral Treatment Timing in Chronic HBV
NCT00810524Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2007
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine, telbivudine, entecavir, adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
lamivudinetelbivudineentecaviradefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00810524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00810524.